Clearance receptors and endopeptidase 24.11: Equal role in natriuretic peptide metabolism in conscious sheep

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 271, Issue 2 40-2, 1996, Pages

  Charles, Christopher J ^a   Espiner, Eric A ^b   Nicholls, M Gary ^b   Richards, A Mark ^b   Yandle, Timothy G ^b   Protter, Andy ^b   Kosoglou, Teddy ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NONE

Author keywords

atrial natriuretic peptide; atrial pressure; brain natriuretic peptide; guanosine 3',5' cyclic monophosphate

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ALPHA; ATRIAL NATRIURETIC FACTOR DERIVATIVE; ATRIAL NATRIURETIC FACTOR RECEPTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; MEMBRANE METALLOENDOPEPTIDASE; N (1 CARBOXY 2 PHENYLETHYL)PHENYLALANYL BETA ALANINE; NATRIURETIC PEPTIDE TYPE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIURESIS; HEART ATRIUM PRESSURE; HEMODYNAMICS; HORMONE METABOLISM; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; SHEEP;

EID: 0029791110     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1996.271.2.r373     Document Type: Article

References (27)

1. Abe, T., Y. Arakawa, A. H. Rajasekarani, T. Yu, and O. Wada. Interaction of atrial natriuretic peptide with its receptors in bovine lung membranes. J. Biol. Chem. 270: 7672-7678, 1995.
2. Almeida, F. A., M. Suzuki, R. M. Scarborough, J. A. Lewicki, and T. Maack. Clearance function of C-type receptors of atrial natriuretic factor in rats. Am. J. Physiol. 256 (Regulatory Integrative Comp. Physiol. 25): R469-R475, 1989.
3. 125I-atrial natriuretic factor in anaesthetized rats. Biochem. Pharmacol. 44: 1013-1022, 1992.
4. Charles, C. J., E. A. Espiner, V. A. Cameron, and A. M. Richards. Hemodynamic, renal, and endocrine actions of ANF in sheep: effect of 24-h, low-dose infusions. Am. J. Physiol. 258 (Regulatory Integrative Comp. Physiol. 27): R1279-R1285, 1990.
5. Charles, C. J., E. A. Espiner, A. M. Richards, M. G. Nicholls, and T. G. Yandle. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R1324-R1331, 1996.
6. Chevalier, R. L., M. Garmey, R. M. Scarborough, J. Linden, R.A. Gomez, M. J. Peach, and R. M. Carey. Inhibition of ANP clearance receptors and endopeptidase 24.11 in maturing rats. Am. J. Physiol. 260 (Regulatory Integrative Comp. Physiol. 29): R121S-R1228, 1991.
7. Chiu, P. J. S., G. Tetzloff, M. T. Ramano, C. J. Foster, and E. J. Sybertz. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats. Am. J. Physiol. 260 (Regulatory Integrative Comp. Physiol. 29): R208-R216, 1991.
8. Dunn, P. J., and E. A. Espiner. Outpatient screening tests for primary aldosteronism.Aust. NZ J. Med. 6: 131-135, 1976.
9. Florkowski, C. M., A. M. Richards, E. A. Espiner, T. G. Yandle, and C. Frampton. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R1244-R1250, 1994.
10. Hashimoto, Y., K. Nakao, N. Hama, H. Imura, S. Mori, M. Yamaguchi, M. Yasuhara, and R. Hori. Clearance mechanisms of atrial and brain natriuretic peptides in rats. Pharm. Res. 11: 60-64, 1994.
11. Hirata, Y., E. Suzuki, H. Hayakawa, H. Matsuoka, T. Sugimoto, K. Kangawa, and H. Matsuo. Mechanisms of the natriuretic effects of neutral endopeptidase inhibition in Dahl salt-sensitive and salt-resistant rats. J. Cardiovasc. Pharmacol. 23: 283-290, 1994.
12. Kenny, A. J., A. Bourne, and J. Ingram. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11. Biochem. J. 291: 83-88, 1993.
13. Kirk, J. E., and M. R. Wikins. Effect of endopeptidase 24.11 inhibition and of atrial natriuretic peptide clearance receptor ligand on the response to rat brain natriuretic peptide in the conscious rat. Br. J. Pharmacol. 110: 350-354, 1993.
14. Koepke, J. P., L. D. Yyler, A. J. Trapani, P. R. Bovy, K. L. Spear, G. M. Olins, and E. H. Blaine. Interaction of nonguanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats. J. Pharmacol. Exp. Ther. 249: 172-176, 1989.
15. Kukkonen, P., O. Vuolteenaho, and H. Ruskoaho. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand. Endocrinology 130: 755-765, 1992.
16. Lang, C. C., A. M. J. Choy, and A. D. Struthers. Atrial and brain natriuretic peptides: a dual natriuretic peptides system potentially involved in circulatory homeostasis. Clin. Sci. 83: 519-527, 1992.
17. Lun, S., E. A. Espiner, M. G. Nicholls, and T. G. Yandle. A direct radioimmunoassay for aldosterone in plasma. Clin. Chem. 29: 268-271, 1983.
18. Maack, T., J. Okolicany, and G. Y. Koh. Functional properties of atrial natriuretic factor receptors. Sem. Nephrol. 13: 50-60, 1993.
19. Maeda, T., K. Balakrishnan, and S. Q. Mehdi. A simple and rapid method for the preparation of plasma membranes. Biochim.Biophys.Acta 731: 115-120. 1995.
20. 1) receptor expressed in mammalian cells. Biochem. J. 299:683-693, 1994.
21. Okolicany, J., G. A. McEnroe, G. Y. Koh, J. A. Lewicki, and T. Maack. Clearance receptor and neutral endopeptidasemediated metabolism of atrial natriuretic factor. Am. J. Physiol. 263 (Renal Fluid Electrolyte Physiol 32): F546-F553, 1992.
22. Seymour, A. A., J. A. Norman, M. M. Asaad, S. A. Fennel, B. Abboa-Offei, D. K. Little, V. J. Kratunis, N. G. Delaney, J. T. Hunt, and G. Di Donato. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors. J. Pharmacol. Exp. Ther. 256: 1002-1009, 1991.
23. Sybertz, E. J. SCH 34826: an overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator. Clin. Nephrol. 36: 187-191. 1991.
24. Vemulapalli, S., P. J. S. Chiu, A. Brown, K. Griscti, and E. J. Sybertz. The blood pressure responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF(4-23) in DOCA-salt hypertensive rats. Life Sci. 49: 383-391, 1991.
25. Yandle, T. G., G. D. Aitken, S. F. Fisher, M. Rademaker, E. A. Espiner, and M. G. Nicholls. Ovine brain natriuretic peptide: identity measurement and regulation (Abstract). J. Hypertens. 12, Suppl. 3: S50. 1994.
26. Yandle, T. G., E. A. Espiner, M. G. Nicholls, and H. Duff. Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. J. Clin. Endocrinol. Metab. 63: 72-79, 1986.
27. Yandle, T., M. Smith, E. Espiner, M. Richards, and G. Nicholls. Natriuretic peptide receptors in sheep lung and adrenal tissue (Abstract). Proc. Endocr. Soc. Aust. 38: NZ20, 1995.